Gemcitabine or Gemzar is used in advanced pancreatic cancer. It is an alternative to 5-fluorouracil and is able to improve survival and reduce pain.
Gemcitabine or Gemzar is an antimetabolite related to cytarabine. It is incorporated into DNA of the fast growing cancerous cells, affecting replication.
Gemcitabine or Gemzar causes immunosuppression, nausea, vomiting, mouth ulcers, fever, rash.
People taking Gemcitabine or Gemzar are immunospressed, meaning that they are at increased risk for infection. Because Gemcitabine or Gemzar can affect the liver, people must be carefully followed for their liver health.
Gemcitabine or Gemzar is often taken as part of a drug regime, thus it may be combined with other chemotherapeutic agents.
FDC Reports 1996;58(21):6
Ann Oncol 1996;7:347
Br J Cancer 1996;73:101
The relevant product monographs must be regarded as the appropriate sources of prescribing information.